Page last updated: 2024-08-21

malondialdehyde and pr 39

malondialdehyde has been researched along with pr 39 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Das, DK; Engelman, RM; Ghatpande, S; Goswami, SK; Gurusamy, N; Muinck, ED; Murakami, M; Nagy, N; Simons, M; Tirziu, D	1

Other Studies

1 other study(ies) available for malondialdehyde and pr 39

Article	Year
Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling. Antioxidants & redox signaling, 2007, Volume: 9, Issue:4 Topics: Adenoviridae; Animals; Antimicrobial Cationic Peptides; Apoptosis; Blotting, Western; Cell Line; Genetic Therapy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mutation; Myocardial Reperfusion Injury; Reactive Oxygen Species; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Time Factors	2007

Article

Year

Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling.

Antioxidants & redox signaling, 2007, Volume: 9, Issue:4

Topics: Adenoviridae; Animals; Antimicrobial Cationic Peptides; Apoptosis; Blotting, Western; Cell Line; Genetic Therapy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mutation; Myocardial Reperfusion Injury; Reactive Oxygen Species; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Time Factors

2007